Manual Acupuncture (MA) for Asymptomatic Hyperuricemia (HUA)
ConditionAsymptomatic Hyperuricemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorShenghao Tu
About this trial
Assess the effectiveness of manual acupuncture in modulating serum uric acid levels among patients diagnosed with asymptomatic hyperuricemia.
Eligibility criteria
Qualifiers
With serum uric acid (SUA) level >7 mg/dL after 1 month of a low-purine diet.
No history of gouty arthritis.
Has not received uric acid-lowering drug treatment or stopped uric acid- lowering drug treatment ≥ 12 weeks.
18.5kg/m2 ≤ body mass index (BMI) ≤ 30.0 kg/m2.
Disqualifiers
Patients with poorly controlled hypertension: systolic blood pressure (SBP) ≥ 160mmHg, diastolic blood pressure (DBP) ≥ 100 mmHg.
Patients with poorly controlled diabetes (hemoglobin A1c ≥ 8.4%).
Patients with severe liver and kidney damage: chronic kidney disease (CKD) ≥ stage 2 or a serum creatinine, urea, alanine, or aspartate aminotransferase level more than twice of the upper limit.
Patients with blood system diseases, such as acute and chronic leukemia, polycythemia, multiple myeloma, hemolytic anemia, lymphoma, or undergoing chemotherapy for multiple solid tumors.
Trial design
Treatments tested in this trial
- Manual acupuncture
- Sham acupuncture
Treatment groups
260 Participants
are divided into 2 treatment groupsSponsors and collaborators
Shenghao Tu
Lead sponsor
Tongji Hospital
Sponsor institution
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborator
Xianning Hospital of Traditional Chinese Medicine, China
Collaborator
Beijing Hospital of Traditional Chinese Medicine
Collaborator
Qianjiang Central Hospital, China
Collaborator
Hainan General Hospital
Collaborator
Yichang Central People's Hospital
Collaborator
Wuhan No.1 Hospital
Collaborator
The Second Hospital of Huangshi
Collaborator
Puyang Hospital of Traditional Chinese Medicine
Collaborator
Source ClinicalTrials.gov